Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
31.82    0.10 (0.32%)
Bid:
31.76
Ask:
31.98
Spread: 0.22 (0.693%)
Market Cap: £504.94m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Equity Raise Post-Transaction Report

15 Oct 2024 16:29

RNS Number : 2983I
THG PLC
15 October 2024
 

 

 

For immediate release

 

 

15 October 2024

THG PLC

Equity Raise Post-Transaction Report

 

In accordance with the Statement of Principles (November 2022) published by the Pre-Emption Group, THG PLC ("THG", the "Company"), announces the following post transaction report in connection with the Company's non-pre-emptive issue of equity securities, as announced on 11 October 2024.

 

Terms defined in the placing announcement issued on 10 October 2024 (the "Placing Announcement") have the same meanings in this announcement unless the context provides otherwise.

 

Name of Issuer

THG PLC

Transaction Details

The Company issued 194,722,333 new Ordinary Shares in total pursuant to the Fundraise (comprising 138,265,306 Placing Shares, 45,408,163 Subscription Shares and 11,048,864 Retail Offer Shares), representing approximately 14.6% of the Company's existing issued Ordinary Shares prior to the Fundraise.

 

Settlement and admission of the Placing Shares, the Subscription Shares and the Retail Offer Shares took place at 8.00 am on 15 October 2024.

Use of Proceeds

As set out in the Placing Announcement and the result of placing announcement issued on 11 October 2024, approximately £75 million of net institutional proceeds of the Fundraise will be used to provide IngenuityCo with sufficient medium-term funding (in tandem with appropriate standalone debt issuance plans) and the net proceeds raised in excess of £75 million will be used for general corporate purposes.

Quantum of Proceeds

The aggregate proceeds from the Fundraise amounted to approximately £95.4 million.

 

Discount

The Placing Price of 49 pence represented a discount of approximately 5.2 per cent. to the closing price on 10 October 2024.

Allocations

Soft pre-emption has been adhered to in the allocations process, where possible. Management was involved in the allocations process, which has been carried out in compliance with the MIFID II Allocation requirements.

Consultation

The Company consulted with a number of its major shareholders prior to the Fundraise, with certain of the Company's long-term shareholders indicating their intention to subscribe for, in aggregate, £33 million of new Ordinary Shares at the Placing Price pre-launch as set out in the Placing Announcement.

Retail Investors

The Fundraise included a Retail Offer via the PrimaryBid platform, for a total of 11,048,864 Retail Offer Shares, raising gross proceeds of approximately £5.4 million.

 

Retail investors, who participated in the Retail Offer, were able to do so at the same Placing Price as all other investors participating in the Fundraise.

 

The Retail Offer was made available to existing shareholders and new investors in the UK. Investors were able to participate through PrimaryBid's platform via its partner network (covering 60+ FCA registered intermediaries) and through PrimaryBid's free-to-use direct channel. Investors had the ability to participate in this transaction through ISAs and SIPPs, as well as General Investment Accounts (GIAs). This combination of participation routes meant that, to the extent practicable on the transaction timetable, eligible UK retail investors (including certificated retail shareholders) had the opportunity to participate in the Capital Raise alongside institutional investors.

 

 

 

 

For further information, please contact:

 

Investor Enquiries:

Greg Feehely, SVP Investor Relations

Kate Grimoldby, Director of Investor Relations and Strategic Projects

Investor.Relations@thg.com

Media enquiries:

 

Sodali & Co - Financial PR adviser

Victoria Palmer-Moore / Russ Lynch

+44 (0)20 7250 1446

thg@sodali.com

THG PLC

Viki Tahmasebi

Viki.tahmasebi@thg.com

Barclays (Joint Global Coordinator, Joint Bookrunner and Joint Corporate Broker):

Alastair Blackman

Dominic Harper

Callum West

+44 (0)20 7623 2323

Jefferies International Limited (Joint Global Coordinator, Joint Bookrunner and Joint Corporate Broker):

Philip Noblet

Ed Matthews

Gavriel Lambert

+44 (0)20 7029 8000

Peel Hunt LLP (Joint Bookrunner) George Sellar Sohail Akbar Andrew Clark

+44 (0)20 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFFAFIIELSEES
Date   Source Headline
4th Apr 20257:00 amRNSCompletion of debt refinancing
1st Apr 202511:55 amRNSTR-1: Notification of Major Holdings
1st Apr 202511:47 amRNSEquity Raise Post-Transaction Report
1st Apr 202510:20 amRNSTR-1: Notification of Major Holdings
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 202511:44 amRNSTR-1: Notification of Major Holdings
31st Mar 202510:45 amRNSPDMR / PCA Shareholding & TR-1 Notification
27th Mar 20257:00 amRNSEquity Contribution confirmation
25th Mar 20257:00 amRNSResults of Placing
24th Mar 20255:45 pmRNSProposed debt refinancing and equity placing
7th Mar 20253:24 pmRNSTR-1: Notification of Major Holdings
6th Mar 20257:00 amRNSInclusion in FTSE 250 Index
3rd Mar 20257:00 amRNSTotal Voting Rights
5th Feb 20259:34 amRNSTR-1: Notification of Major Holdings
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20257:01 amRNSTR-1: Notification of Major Holdings
28th Jan 20257:00 amRNSAppointment of Independent Non-Executive Director
23rd Jan 20257:00 amRNSQ4 2024 Trading Statement
20th Jan 20255:12 pmRNSNotice of Results
13th Jan 20257:00 amRNSTR-1: Notification of Major Holdings
9th Jan 20252:29 pmRNSTR-1: Notification of Major Holdings
8th Jan 202512:51 pmRNSDirectorate Change
7th Jan 20258:26 amRNSPDMR/PCA Shareholdings
6th Jan 202512:30 pmRNSTR-1: Notification of Major Holdings
6th Jan 20259:09 amRNSTransfer to ESCC Category
3rd Jan 20251:29 pmRNSTR-1: Notification of Major Holdings
2nd Jan 20254:04 pmRNSTR-1: Notification of Major Holdings
2nd Jan 20254:02 pmRNSTR-1: Notification of Major Holdings
2nd Jan 20252:09 pmRNSCompletion of Demerger
2nd Jan 20257:00 amRNSTotal Voting Rights
27th Dec 20242:36 pmRNSResults of General Meeting
17th Dec 20245:20 pmRNSIngenuity Shareholders’ Agreement & Articles
28th Nov 20247:01 amRNSIngenuity Demerger Circular and Notice of GM
28th Nov 20247:00 amRNSESCC transfer effective date, Index eligibility
27th Nov 20243:26 pmRNSAppointment of Corporate Broker
1st Nov 20247:00 amRNSBlock Listing Six Monthly Return
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSTR-1: Notification of Major Holdings
16th Oct 20247:00 amRNSPDMR/PCA Shareholdings
15th Oct 20244:41 pmRNSTR-1: Notification of Major Holdings
15th Oct 20244:29 pmRNSEquity Raise Post-Transaction Report
15th Oct 20244:27 pmRNSTR-1: Notification of Major Holdings
15th Oct 20244:24 pmRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSResults of Placing
10th Oct 20244:54 pmRNSLaunch of Retail Offer
10th Oct 20244:52 pmRNSUpdate on Ingenuity Demerger and Proposed Placing
10th Oct 20244:50 pmRNSQ3 2024 Trading Statement
4th Oct 202410:09 amRNSTR-1: Notification of Major Holdings
1st Oct 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.